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Australia has 4 rickettsial diseases: murine typhus,
Queensland tick typhus, Flinders Island spotted fever, and
scrub typhus. We describe 7 cases of a rickettsiosis with an
acute onset and symptoms of fever (100%), headache
(71%), arthralgia (43%), myalgia (43%), cough (43%), mac-
ulopapular/petechial rash (43%), nausea (29%), pharyngi-
tis (29%), lymphadenopathy (29%), and eschar (29%).
Cases were most prevalent in autumn and from eastern
Australia, including Queensland, Tasmania, and South
Australia. One patient had a history of tick bite
(Haemaphysalis novaeguineae). An isolate shared 99.2%,
99.8%, 99.8%, 99.9%, and 100% homology with the 17
kDa, ompA, gltA, 16S rRNA, and Sca4 genes, respective-
ly, of Rickettsia honei. This Australian rickettsiosis has sim-
ilar symptoms to Flinders Island spotted fever, and the
strain is genetically related to R. honei. It has been desig-
nated the “marmionii” strain of R. honei, in honor of
Australian physician and scientist Barrie Marmion.
A
ustralia has several endemic rickettsial diseases. In
addition, epidemic typhus arrived with the first fleet
in 1788 (1), but the disease did not become established in
Australia. The current endemic rickettsial diseases are
murine typhus (Rickettsia typhi), scrub typhus (Orientia
tsutsugamushi), and the spotted fever group (SFG) dis-
eases—Queensland tick typhus (QTT; R. australis) and
Flinders Island spotted fever (FISF; R. honei) (2).
QTT, first described in 1946, was characterized as a
relatively mild disease with symptoms of fever, headache,
malaise, enlarged lymph nodes, and a maculopapular
(sometimes vesicular) rash. Most patients have an eschar
and some have a slight cough, myalgia, and chills (3,4).
Cases of QTT have been detected only on the eastern
seaboard of mainland Australia, with most originating in
late winter (5). FISF was described in Australia, in 1991. It
is found in southeastern Australia and is characterized by
fever, headache, myalgia, transient arthralgia, macu-
lopapular rash, and cough in some cases (6,7). Most cases
occur in summer. Both QTT and FISF are transmitted to
humans by tick bites. Ticks of the genus Ixodes, especially
I. holocyclus, are the main arthropod hosts of QTT and
Bothriocroton hydrosauri (formerly  Aponomma hydro-
sauri) are the main hosts of FISF (8–10).
We describe 7 cases of a rickettsial disease similar to
FISF, which occurred in the eastern half of Australia. The
etiologic agent of this disease is an SFG rickettsia, geneti-
cally related to R. honei and less closely related to R. aus-
tralis. The etiologic agent of the rickettsiosis has been
designated the “marmionii” strain of R. honei.
Case Reports
Patient 1
A 37-year-old woman from Port Willunga, South
Australia, sought treatment in February 2003, with a 2-
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eschar was seen, and she had no recollection of arthropod
exposure. She had traveled to Kangaroo Island 2–3 weeks
before the onset of illness. Laboratory tests showed elevat-
ed levels of liver function test enzymes, mild leukopenia,
and thrombocytopenia. Her health improved after receiv-
ing oral doxycycline for 5 days. Rickettsial serology later
showed an increase in antibody titer. Both PCR and culture
results were positive for an SFG rickettsia (Table 1).
Patient 2
A 9-year-old girl sought treatment at the Darnley
Island Health Clinic, Torres Strait, Queensland, in
February 2003. She was febrile (38.5°C) and reported
headache, nausea, and abdominal pain. She had no eschar
or rash. She was initially thought to have a viral illness;
however, after 3 days she was still febrile (39.0°C), and the
provisional diagnosis was changed to scrub typhus; a reg-
imen of oral doxycycline, 100 mg per day, was begun. She
was not seen by medical or nursing staff between day 3
and 8 of the illness, but was afebrile and well by day 8. Her
SFG title increased, despite a 6-month delay in obtaining
the convalescent-phase serum. Results of culture and PCR
of the blood sample taken on day 8 were positive for an
SFG rickettsia (Table 1).
Patient 3
A 27-year-old man sought treatment at the Darnley
Island Health Clinic in March 2003. His temperature was
37.4°C, and he reported headache, arthralgia, and cough.
He exhibited no eschar or rash. The provisional diagnosis
was of viral upper respiratory tract infection. He was seen
again on days 3 and 4 with persisting symptoms and a sore
throat. On the latter visit his condition was diagnosed as
tonsillitis, and treatment with penicillin V was begun.
Blood tests for malaria and scrub typhus were initiated. He
returned on day 29 with fever (37.6°C), cough, pharyngi-
tis, and arthralgia. Results of serologic investigations for
Plasmodium falciparum and rickettsia (taken on day 3)
were negative. Antibiotics were not given because the ill-
ness was thought to be viral. His symptoms resolved with-
in the following 2 weeks. Antirickettsial antimicrobial
agents were not given at any stage during the illness. Day
3 serum and follow-up serum specimens obtained 6
months later were both negative for rickettsial antibodies;
however, results of PCR and culture on the day 3 blood
specimen were positive for SFG rickettsiae (Table 1).
Patient 4
A 10-year-old boy was brought to the Yam Island
Health Clinic, Torres Strait, Queensland, in May 2003, five
days into an illness with manifestations of fever (38.1°C),
headache, and cough. Diagnostic tests for scrub typhus,
malaria and leptospirosis were initiated but he was given
no specific antimicrobial therapy. Two days later, he
seemed improved, and a provisional diagnosis of viral
upper respiratory tract infection was made. However,
when he was seen on day 14, some symptoms remained
(cough and headache), and treatment with amoxicillin was
begun. He was well when examined on day 22. At no stage
was he given antirickettsial therapy. His day 5 blood sam-
ple was negative for SFG/typhus group (TG) rickettsial
antibodies, but results of PCR and culture were positive for
a SFG rickettsia. Follow-up serum taken 14 months later
was negative for rickettsial antibody (Table 1).
Patient 5
A50-year-old man was admitted to Innisfail Hospital,
Innisfail, Queensland, in June 2003. He reported a 7-day
history of fever and rigors and a 4-day history of macu-
lopapular rash. He also reported myalgia, arthralgia, con-
junctivitis, swollen hands, dry cough, and constipation. An
eschar was found on the right side of his neck. His temper-
ature was 38.5°C and blood pressure 95/60 mm Hg. Serum
chemistry showed elevated levels of total bilirubin (23;
normal range 2–20 µmol/L), alkaline phosphatase (276;
normal range 30–115 units/L), gamma-glutamyl transpep-
tidase (199; normal range 0–70 units/L), aspartate
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nine transaminase (ALT) (129; normal range 5–40
units/L), and lactate dehydrogenase (LDH) (701, normal
range 100–225 units/L). Further investigation showed pro-
teinuria, moderate thrombocytopenia (59; normal range
150–400×109/L), mild neutrophilia with left shift (7.9;
normal range 2.0–7.5 × 109/L), and lymphopenia (0.7; nor-
mal range 1.0–4.0 × 109/L). Examination of convalescent-
phase serum showed seroconversion to SFG rickettsia.
Results of rickettsial PCR and culture were positive for a
member of the SFG (Table 1). He recovered after treatment
with oral doxycycline (100 mg twice per day) for 5 days.
Patient 6
A 33-year-old man from Lilydale, a small town in
northeastern Tasmania, sought treatment from his general
practitioner in May 2003 (day 1) after a recent fishing trip.
His symptoms included fever (38.3°C) and headache. On
day 6 the patient was improving but had developed cervi-
cal lymphadenopathy. His illness was thought to be viral in
origin so he was not treated with any antibiotics. The
patient’s condition improved, and he had a symptom-free
period of ≈10 days. Fever developed again 33 days after
onset of the earlier illness with the same symptoms includ-
ing aches and pains. Three days later, he was admitted to
Launceston General Hospital. He appeared markedly ill
with a blanching maculopapular rash that had not been evi-
dent before, over his trunk, inguinal lymphadenopathy,
neutropenia (0.9; normal range 2.0–7.5 × 109/L) and
slightly elevated levels of C-reactive protein (10; normal
range 0–8 mg/L). At this time the possibility of rickettsial
disease was raised, and appropriate tests were performed.
On day 7 after the second onset of fever, the patient
was able to work but still felt ill and had a slight fever
(37.6°C). On day 27 after the second onset of fever, more
rickettsial tests were performed before he received treat-
ment with a 14-day course of doxycycline. He made a
complete recovery without further relapse. He showed a
raised rickettsial SFG titer and a positive SFG rickettsial
PCR results for both blood samples tested (days 34 and 60)
(Table 1).
Patient 7
A 55-year-old man, an entomologist, at Iron Range,
Cape York Peninsula in far north Queensland, removed a
tick from the left ventrolateral side of his abdomen in late
May 2002. Five days after removing the tick (day 5), an
influenzalike illness with myalgia and arthralgia devel-
oped. On day 6, a high fever developed, and on the follow-
ing day, he experienced persisting severe lethargy and
severe muscle cramps in major muscle groups of his upper
and lower legs. On day 8, an eschar appeared at the site of
the tick bite. It was oval in shape and ≈150 mm by 75 mm.
A widespread maculopapular/petechial rash also appeared
over his body. High fever, severe lethargy, and myalgias
continued. On day 9, he visited his doctor in Brisbane
where the examination confirmed a widespread macu-
lopapular/petechial rash with generalized lymphadenopa-
thy and myalgias affecting large muscle groups. A large
eschar was found on his left lower abdomen. An SFG ill-
ness was suspected, and treatment with doxycycline, 100
mg twice per day, was begun His doctor reexamined him
on day 20, and his condition had improved. His myalgia
had decreased, and the rash faded over 5 weeks.
Laboratory testing on day 10 showed lymphopenia
(0.8; normal range 1.0–4.0 × 109/L) and mild thrombocy-
topenia (146; normal range 150–400 × 109/L). Liver func-
tion tests showed slightly elevated AST (48; normal range
5–40 units/L) and ALT (44, normal range 5–40 units/L)
and mildly elevated LDH (325; normal range 100–225
units/L). Rickettsial serology was negative on day 10 but
convalescent-phase serology on day 23 showed an SFG
seroconversion. A real-time PCR on the day 10 serum
specimen showed a positive result for the SFG/TG gltA
gene, but the 17-kDa PCR result was negative (Table 1).
The removed tick was subsequently identified as
Haemaphysalis novaeguineae. DNA was extracted from
the tick and PCRs performed targeting the rickettsial rrs,
ompA and ompB genes. PCR products were sequenced,
aligned, searched with BLAST (available from
http://130.14.29.110/BLAST/), and submitted to GenBank
(accession nos. AJ585043, AJ585044, and AJ585045 for
the  rrs,  ompA, and  ompB genes, respectively). Phylo-
genetic analysis of all 3 genes showed that the closest
relatives were R. honei strain TT-118 (Thai tick typhus)
and R. honei strain RB (FISF) (11).
Methods
Rickettsial Serology
Serologic testing was performed on human serum
specimens by using a goat anti-human IgM, IgG, and IgA
fluorescein isothiocyanate–labeled secondary antibody
(Kirkegaard and Perry Laboratories, Gaithersburg, MD,
USA), by an indirect immunofluorescence assay (IFA) as
described (7). Antigens used included R. honei, R. aus-
tralis, R. akari, R. conorii, R. sibirica, and R. rickettsii
from the SFG; and R. typhi and R. prowazekii from the TG.
All titers >128 were considered positive.
Rickettsia Isolation from Blood 
Rickettsial isolation was performed with Vero cell cul-
tures as previously described (12). Cultures were observed
microscopically weekly for a cytopathic effect and month-
ly by immunofluorescence. IFA-positive cultures had their
DNA extracted and their rickettsial status confirmed by
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XTC-2 cell monolayers and grown at 28°C in Leibovitz L-
15 media (Invitrogen, Melbourne, Victoria, Australia) sup-
plemented with 5% heat-inactivated fetal bovine serum,
0.4% tryptose phosphate (Oxoid, Basingstoke, UK), and
200 mmol/L-glutamine (Invitrogen).
Rickettsial PCR on Blood
Rickettsial real-time PCR was performed on buffy
coat (except for serum for case 7). DNA was extracted by
using a DNA extraction kit (Gentra, Minneapolis, MN,
USA) and the primers CS-F and CS-R and the probe CS-P
(Table 2; Biosearch Technologies Inc., Novato, CA, USA)
as previously described (13).
Confirmatory PCR was performed on the 17-kDa
gene (orf17) by using the primers MTO-1 and MTO-2
(Table 2; Invitrogen) (14), with an annealing temperature
of 51°C and a total of 45 cycles. PCR products were visu-
alized by electrophoreses on a 1% Tris-acetate EDTA
agarose gel (Amresco, Solon, CA, USA) stained with
ethidium bromide. PCR-positive samples had their DNA
cleansed using the QIAquick DNAclean up kit (QIAGEN,
Düsseldorf, Germany) and were sequenced at Newcastle
DNA (Newcastle University, Newcastle, New South
Wales, Australia). Phylogenetic analysis of DNA
sequences was performed with DNADIST and NEIGH-
BOR computer programs of the PHYLIPversion 3.63 soft-
ware package (available from http://evolution.genetics.
washington.edu/phylip.html). Sequences were compared
to those of the rickettsial strains considered to be valid
species (19). Phylogenetic trees and bootstrap analyses
were performed with 100 alignments by using the SEQ-
BOOT and CONSENSE programs of PHYLIP.
Rickettsial Molecular Characterization
Rickettsial isolates had portions of their gltA, 16S
rRNA, ompA, and Sca4 antigen genes amplified and
sequenced to supplement the 17-kDa gene analysis done on
buffy coat and cultures. The primer pairs CS-162-F with
CS-731-SR and CS-398-SF with RpCS1258 (Table 2) were
used to amplify the 5′ and 3′ ends of gltA, respectively (15).
The 16S rRNA gene (rrs) was amplified by using the
primer pairs rRNA1 with rRNA3 and rRNA2 with rRNA4
(Table 2) (17). The PCR contained 1 µmol of each respec-
tive primer, 200 µmol/Lof each dNTP, 10× reaction buffer,
2 mmol/L MgCl2, 2 U Taq polymerase, and 4 µL of rick-
ettsial DNA extract. The amplification was performed in a
thermocycler (Rotor-Gene 3000, Corbett Research,
Sydney, New South Wales, Australia) with an initial denat-
uration of 95°C for 3min, followed by 40 cycles of denat-
uration at 95°C for 30 s, annealing at 51°C for 30 s, and
extension at 72°C for 1 min; with a final extension of 10
min. PCR products were visualized and sequenced as
described above.
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primers Rr190.70p and Rr190.602n (Table 2) by using the
above protocol but with an annealing temperature of 48°C
(16). The Sca4 antigen gene (sca4) was amplified by using
the primer pairs D1f and D928r, D767f and D1390r,
D1219f and D1876r, and D1738f and D2482r, following
the specified protocol (18). The final segment of the gene
was amplified with the primers D2338f and D3069r fol-
lowing the same protocol and an annealing temperature of
48°C (18).
Results
Seroconversion, defined as a 4-fold increase in anti-
body titer, occurred in only 2 of the 7 patients (patients 5
and 7), although positive titers were seen in 5 of 7 patients
(Table 1). In 5 of 6 patients a rickettsia was isolated from
blood (in EDTA-vacutainers; Table 1) in Vero cell culture,
however, 4 of these 5 isolates did not persist in cell culture
after their third passage. The remaining isolate, from
patient 5, has been maintained in continuous culture in
only the XTC-2 cell line.
Patients 1–6 had rickettsial DNA detected in their
buffy coat DNA extracts by real-time PCR. Patient 7 had
rickettsial DNA detected in his serum by using real-time
PCR. Of the 7 cases, all but 1 (patient 7), were PCR posi-
tive for the 17-kDa gene and all 5 positive rickettsial cul-
tures were also PCR positive for the same gene (Table 1).
The 17-kDa PCR sequences for the buffy coats of cases
1–6 and cultures of patients 1–5 were found to be 100%
homologous to one another and to the Japanese
Haemaphysalis tick sequences Hf151 and Hl550 (20)
(GenBank accession nos. AB114816 and AB114807,
respectively). A 399-bp sequence also exhibited 99.2%
homology with R. honei strains RB and TT-118 (GenBank
accession nos. AF060704 and AF060706, respectively) as
shown in the phylogenetic tree (Figure).
Analysis of a 1082 bp gltA sequence from the KB
strain exhibited 99.7 and 99.8% homology with R. honei
strains RB and TT-118, respectively (GenBank accession
nos. AF018074 and U59726, respectively) (Figure). An
1142 bp rrs sequence exhibited 100% homology with the
Australian  Haemaphysalis novaeguineae tick sequence
AL2003 (11) (GenBank accession no. AJ585043) and a
1,388-bp sequence exhibited 99.6% and 99.9% homology
with the R. honei strains RB and TT-118, respectively
(GenBank accession nos. U17645 and L36220, respective-
ly) (Figure). A 511-bp sequence of ompA exhibited 100%
homology with the H. novaeguineae sequence AL2003
(11) (GenBank accession no. AJ585044) and a 513-bp
sequence had 99.8% homology with the R. honei strains
RB and TT-118 (GenBank accession nos. AF018075 and
U43809, respectively). Only 1 nucleotide substitution was
found in a 2,961-bp sequence of the Sca4 gene (100%
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Figure. Phylogenetic trees obtained by a neighbor-joining analysis
of the 16s RNA, gltA, 17-kDa, ompA, and Sca4 antigen genes.
Bootstrap values from 100 analyses are shown at the node of
each branch.homology) with R. honei strain RB (GenBank accession
no. AF163004) (Figure).
These  R. honei strain “marmionii” sequences have
been submitted to GenBank with the accession nos.
AY37683 for the 17-kDa gene, AY37684 for the gltA gene,
AY37685 for the 16S rRNA gene, DQ309095 for the Sca4
gene, and DQ309096 for the ompA gene.
Discussion
These 7 cases of FISF are an example of many newly
emerging rickettsial diseases (21). Its symptoms are con-
sistent with a relatively mild rickettsial SFG disease. The
most frequent acute symptoms observed were fever
(100%), headache (71%), arthralgia (43%), myalgia
(43%), cough (43%), rash (maculopapular/petechial)
(43%), nausea (29%), pharyngitis (29%), and lym-
phadenopathy (29%). In only 2 patients was an eschar evi-
dent. The rash did not appear on the palms or soles, unlike
previously reported FISF cases (6,12). One patient (patient
7), had a history of a H. novaeguineae tick bite, which may
imply an incubation period of 5 days. The cases in this
report occurred between February and June (late summer
and autumn), in contrast to previously described cases of
FISF and QTT, which have their peak onsets in summer
and late winter, respectively (5,6).
The biphasic illnesses seen in patients 3 and 6 were
unusual for SFG rickettsial diseases. Because no speci-
mens were taken during the initial phase of either patient’s
illness, that this phase was rickettsial in nature cannot be
confirmed. Patient 6’s illness may have been rickettsial in
nature because of the appropriate incubation time after a
fishing trip in an area endemic for ticks. His illness had the
longest duration of all the reported cases, with rickettsiae
still detectable 27 days after the onset of the second febrile
illness. This is possibly the first report of an SFG rickettsia
being associated with a chronic infection in a human.
Relapsing rickettsial diseases are known to exist, such as
Brill disease, a recurrent form of epidemic typhus (22).
Rickettsiae persisting in human and animal organs after ill-
ness have been reported with scrub typhus and SFG rick-
ettsia (23,24). An Australian case of recurrent rickettsial
illness was diagnosed serologically as QTT (25).
The isolation of rickettsiae from patient 2 after antimi-
crobial drug therapy and while she was clinically well is
unusual. The presence of rickettsiae may be due to the bac-
teriostatic nature of the patient’s treatment, which allowed
a small number of rickettsiae to survive before being elim-
inated by her immune system. This phenomenon may also
have been the beginning of a chronic infection, as
described above in patients 3 and 6.
Apart from patients 5 and 7, antibody levels of paired
serum specimens (Table 1) did not show a marked rise in
titer. Because the second serum sample from 4 of the case-
patients was received in excess of 6 months after illness,
the antibody levels may have subsided, explaining the
apparent lack of seroconversion in patients 3 and 4.
Because most rickettsioses are diagnosed through serolog-
ic tests, some cases of rickettsial disease are likely being
missed due to a lack of seroconversion, as we have
observed with these cases of FISF. This demonstrates the
usefulness of PCR for diagnosing acute rickettsial dis-
eases. Cases of rickettsioses without seroconversion or
positive serology titers have been previously described
with “R. sibirica mongolotimonae” (26). Despite the initial
isolation of R. honei strain “marmionii” in Vero and L929
cells at 35°C, no isolate could be continuously grown in
these cell lines. This may be due partially to temperature-
dependent growth kinetics, similar to those of R. felis (27).
The 7 described cases were distributed widely
throughout eastern Australia. Cases have appeared on the
eastern seaboard of Australia (including the Torres Strait),
Tasmania, and in South Australia. Cases are yet to be
reported in Victoria, New South Wales, the Northern
Territory, or Western Australia. The discovery of FISF
cases in the Torres Strait suggests its possible presence in
Papua New Guinea. In comparison, QTT is found only
down the eastern seaboard and not south or west of
Wilson’s Promontory in Victoria. Traditionally, FISF has
only been found in the southeastern states, including
Tasmania and South Australia (6,12,28).
At present, R. honei has been found on 2 other conti-
nents, with potential reservoirs in Ixodes and
Rhipicephalus ticks in Asia and in Amblyomma cajennense
in North America (29). The only known vector/reservoir of
R. honei in Australia is Bothriocroton hydrosauri (10). R.
honei strain “marmionii” has not been found in any B.
hydrosauri ticks, although H. novaeguineae may be a vec-
tor/reservoir, as a H. novaeguineae tick was removed from
patient 7 before the onset of illness. Rickettsial rrs and
ompA gene sequences within the tick demonstrated 100%
homology with R. honei strain “marmionii” (11).  H.
novaeguineae is known to bite numerous animals includ-
ing humans and is found in both northern Australia and
Papua New Guinea (30). The vectors and reservoirs of R.
honei strain “marmionii” in southern Australia are not
known.
When compared phylogenetically to other rickettsiae,
R. honei strain “marmionii” has the closest homology with
Australian R. honei strain RB, which had been isolated
from a febrile patient on Flinders Island. When the gltA,
rrs, ompA, orf17, and sca4 genes are compared between R.
honei strains RB and “marmionii,” they are 99.7%, 99.6%,
99.6%, 99.0%, and 100% homologous, respectively.
Homologies of 99.8% and 99.9% are seen with the gltA
and rrs genes, respectively, when R. honei strains TT-118
and “marmionii” are compared. An 811-bp ompB gene
"marmionii" Strain of Rickettsia honei
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patient 7 also showed 100% homology with R. honei (11).
This supports its description as an SFG rickettsia but not a
new species by using previously proposed criteria (19).
Further analysis is needed to further define the taxonomic
position of R. honei strain “marmionii.”
The 7 cases of an illness similar to FISF demonstrate
that new emerging rickettsioses are present in Australia.
These described cases encompass a geographic distribu-
tion larger than those of FISF and QTT. The only known
tick host of R. honei strain “marmionii” is H.
novaeguineae, a tick not previously recognized as a trans-
mitter of human pathogens. Genetically, the etiologic agent
of these 7 cases is closely related to R. honei. We propose
to name the agent Rickettsia honei strain “marmionii,” in
honor of the Australian physician and scientist Barrie P.
Marmion, for his research into Q fever, another important
rickettsial disease.
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